{
  "DOI": "10.1007/s10689-013-9681-4",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-013-9681-4",
  "alternative-id": [
    "9681"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Pan",
      "given": "Xin-Min",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Jia",
      "given": "Jing",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Guo",
      "given": "Xiao-Min",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Li",
      "given": "Zhao-Hui",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zhang",
      "given": "Zhen",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Qin",
      "given": "Hao-Jie",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Xu",
      "given": "Guo-Hui",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Gao",
      "given": "Lin-Bo",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2013,
        8,
        30
      ]
    ],
    "date-time": "2013-08-30T10:41:26Z",
    "timestamp": 1377859286000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        7,
        22
      ]
    ],
    "date-time": "2019-07-22T16:32:52Z",
    "timestamp": 1563813172000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        8,
        22
      ]
    ],
    "date-time": "2023-08-22T02:06:09Z",
    "timestamp": 1692669969847
  },
  "is-referenced-by-count": 7,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2013,
        8,
        31
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2014,
          3
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2013,
            8,
            31
          ]
        ],
        "date-time": "2013-08-31T00:00:00Z",
        "timestamp": 1377907200000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-013-9681-4.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-013-9681-4/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-013-9681-4",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "93-97",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2013,
        8,
        31
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2013,
        8,
        31
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2014,
        3
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/S1044579X02000858",
      "author": "MC Yu",
      "doi-asserted-by": "crossref",
      "first-page": "421",
      "issue": "6",
      "journal-title": "Semin Cancer Biol",
      "key": "9681_CR1",
      "unstructured": "Yu MC, Yuan JM (2002) Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 12(6):421–429",
      "volume": "12",
      "year": "2002"
    },
    {
      "DOI": "10.1046/j.1365-2273.2001.00449.x",
      "author": "AL McDermott",
      "doi-asserted-by": "crossref",
      "first-page": "82",
      "issue": "2",
      "journal-title": "Clin Otolaryngol Allied Sci",
      "key": "9681_CR2",
      "unstructured": "McDermott AL, Dutt SN, Watkinson JC (2001) The aetiology of nasopharyngeal carcinoma. Clin Otolaryngol Allied Sci 26(2):82–92",
      "volume": "26",
      "year": "2001"
    },
    {
      "DOI": "10.1001/archotol.129.7.794",
      "author": "TP Farias",
      "doi-asserted-by": "crossref",
      "first-page": "794",
      "issue": "7",
      "journal-title": "Arch Otolaryngol Head Neck Surg",
      "key": "9681_CR3",
      "unstructured": "Farias TP, Dias FL, Lima RA, Kligerman J, de Sa GM, Barbosa MM, Goncalves FB Jr (2003) Prognostic factors and outcome for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 129(7):794–799. doi: 10.1001/archotol.129.7.794",
      "volume": "129",
      "year": "2003"
    },
    {
      "DOI": "10.1017/S1462399407000312",
      "author": "Q Tao",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "issue": "12",
      "journal-title": "Expert Rev Mol Med",
      "key": "9681_CR4",
      "unstructured": "Tao Q, Chan AT (2007) Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Expert Rev Mol Med 9(12):1–24. doi: 10.1017/S1462399407000312",
      "volume": "9",
      "year": "2007"
    },
    {
      "DOI": "10.1002/cncr.20768",
      "author": "BB Ma",
      "doi-asserted-by": "crossref",
      "first-page": "22",
      "issue": "1",
      "journal-title": "Cancer",
      "key": "9681_CR5",
      "unstructured": "Ma BB, Chan AT (2005) Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinoma. Cancer 103(1):22–31. doi: 10.1002/cncr.20768",
      "volume": "103",
      "year": "2005"
    },
    {
      "author": "T Yoshizaki",
      "journal-title": "Cancer Lett",
      "key": "9681_CR6",
      "unstructured": "Yoshizaki T, Kondo S, Wakisaka N, Murono S, Endo K, Sugimoto H, Nakanishi S, Tsuji A, Ito M (2013) Pathogenic role of Epstein–Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma. Cancer Lett. doi: 10.1016/j.canlet.2013.05.018",
      "year": "2013"
    },
    {
      "DOI": "10.1534/g3.112.005371",
      "doi-asserted-by": "crossref",
      "key": "9681_CR7",
      "unstructured": "Moumad K, Lascorz J, Bevier M, Khyatti M, Ennaji MM, Benider A, Huhn S, Lu S, Chouchane L, Corbex M, Hemminki K, Forsti A (2013) Genetic polymorphisms in host innate immune sensor genes and the risk of nasopharyngeal carcinoma in North Africa. G3 (Bethesda). doi: 10.1534/g3.112.005371"
    },
    {
      "DOI": "10.1186/1741-7015-11-149",
      "author": "S Savas",
      "doi-asserted-by": "crossref",
      "first-page": "149",
      "issue": "1",
      "journal-title": "BMC Med",
      "key": "9681_CR8",
      "unstructured": "Savas S, Liu G, Xu W (2013) Special considerations in prognostic research in cancer involving genetic polymorphisms. BMC Med 11(1):149. doi: 10.1186/1741-7015-11-149",
      "volume": "11",
      "year": "2013"
    },
    {
      "author": "H Kaneda",
      "first-page": "91",
      "journal-title": "Cancer Manag Res",
      "key": "9681_CR9",
      "unstructured": "Kaneda H, Yoshida T, Okamoto I (2013) Molecularly targeted approaches herald a new era of non-small-cell lung cancer treatment. Cancer Manag Res 5:91–101. doi: 10.2147/CMAR.S32973",
      "volume": "5",
      "year": "2013"
    },
    {
      "author": "JK Sicklick",
      "journal-title": "J Gastrointest Surg",
      "key": "9681_CR10",
      "unstructured": "Sicklick JK, Lopez NE (2013) Optimizing surgical and imatinib therapy for the treatment of gastrointestinal stromal tumors. J Gastrointest Surg. doi: 10.1007/s11605-013-2243-0",
      "year": "2013"
    },
    {
      "author": "O Kranenburg",
      "first-page": "81",
      "issue": "2",
      "journal-title": "Biochim Biophys Acta",
      "key": "9681_CR11",
      "unstructured": "Kranenburg O (2005) The KRAS oncogene: past, present, and future. Biochim Biophys Acta 1756(2):81–82. doi: 10.1016/j.bbcan.2005.10.001",
      "volume": "1756",
      "year": "2005"
    },
    {
      "DOI": "10.1242/jcs.085050",
      "author": "M Deng",
      "doi-asserted-by": "crossref",
      "first-page": "2997",
      "issue": "Pt 17",
      "journal-title": "J Cell Sci",
      "key": "9681_CR12",
      "unstructured": "Deng M, Tang H, Zhou Y, Zhou M, Xiong W, Zheng Y, Ye Q, Zeng X, Liao Q, Guo X, Li X, Ma J, Li G (2011) miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma. J Cell Sci 124(Pt 17):2997–3005. doi: 10.1242/jcs.085050",
      "volume": "124",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.cell.2005.01.014",
      "author": "SM Johnson",
      "doi-asserted-by": "crossref",
      "first-page": "635",
      "issue": "5",
      "journal-title": "Cell",
      "key": "9681_CR13",
      "unstructured": "Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D, Slack FJ (2005) RAS is regulated by the let-7 microRNA family. Cell 120(5):635–647. doi: 10.1016/j.cell.2005.01.014",
      "volume": "120",
      "year": "2005"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-08-2129",
      "author": "LJ Chin",
      "doi-asserted-by": "crossref",
      "first-page": "8535",
      "issue": "20",
      "journal-title": "Cancer Res",
      "key": "9681_CR14",
      "unstructured": "Chin LJ, Ratner E, Leng S, Zhai R, Nallur S, Babar I, Muller RU, Straka E, Su L, Burki EA, Crowell RE, Patel R, Kulkarni T, Homer R, Zelterman D, Kidd KK, Zhu Y, Christiani DC, Belinsky SA, Slack FJ, Weidhaas JB (2008) A SNP in a let-7 microRNA complementary site in the KRAS 3′ untranslated region increases non-small cell lung cancer risk. Cancer Res 68(20):8535–8540. doi: 10.1158/0008-5472.CAN-08-2129",
      "volume": "68",
      "year": "2008"
    },
    {
      "DOI": "10.1093/carcin/bgp099",
      "author": "BC Christensen",
      "doi-asserted-by": "crossref",
      "first-page": "1003",
      "issue": "6",
      "journal-title": "Carcinogenesis",
      "key": "9681_CR15",
      "unstructured": "Christensen BC, Moyer BJ, Avissar M, Ouellet LG, Plaza SL, McClean MD, Marsit CJ, Kelsey KT (2009) A let-7 microRNA-binding site polymorphism in the KRAS 3′ UTR is associated with reduced survival in oral cancers. Carcinogenesis 30(6):1003–1007. doi: 10.1093/carcin/bgp099",
      "volume": "30",
      "year": "2009"
    },
    {
      "DOI": "10.1002/hed.21792",
      "author": "WY Wang",
      "doi-asserted-by": "crossref",
      "first-page": "663",
      "issue": "5",
      "journal-title": "Head Neck",
      "key": "9681_CR16",
      "unstructured": "Wang WY, Chien YC, Wong YK, Lin YL, Lin JC (2012) Effects of KRAS mutation and polymorphism on the risk and prognosis of oral squamous cell carcinoma. Head Neck 34(5):663–666. doi: 10.1002/hed.21792",
      "volume": "34",
      "year": "2012"
    },
    {
      "author": "ZH Li",
      "journal-title": "Tumour Biol",
      "key": "9681_CR17",
      "unstructured": "Li ZH, Pan XM, Han BW, Guo XM, Zhang Z, Jia J, Gao LB (2013) A let-7 binding site polymorphism rs712 in the KRAS 3′ UTR is associated with an increased risk of gastric cancer. Tumour Biol. doi: 10.1007/s13277-013-0885-x",
      "year": "2013"
    },
    {
      "DOI": "10.1177/1470320311426168",
      "author": "ZH Li",
      "doi-asserted-by": "crossref",
      "first-page": "210",
      "issue": "1",
      "journal-title": "J Renin Angiotensin Aldosterone Syst",
      "key": "9681_CR18",
      "unstructured": "Li ZH, Pan XM, Han BW, Han HB, Zhang Z, Gao LB (2012) No association between ACE polymorphism and risk of nasopharyngeal carcinoma. J Renin Angiotensin Aldosterone Syst 13(1):210–215. doi: 10.1177/1470320311426168",
      "volume": "13",
      "year": "2012"
    },
    {
      "DOI": "10.1371/journal.pone.0056128",
      "author": "HL Ruan",
      "doi-asserted-by": "crossref",
      "first-page": "e56128",
      "issue": "2",
      "journal-title": "PLoS ONE",
      "key": "9681_CR19",
      "unstructured": "Ruan HL, Qin HD, Shugart YY, Bei JX, Luo FT, Zeng YX, Jia WH (2013) Developing genetic epidemiological models to predict risk for nasopharyngeal carcinoma in high-risk population of China. PLoS ONE 8(2):e56128. doi: 10.1371/journal.pone.0056128",
      "volume": "8",
      "year": "2013"
    },
    {
      "author": "WQ Xue",
      "journal-title": "Am J Epidemiol",
      "key": "9681_CR20",
      "unstructured": "Xue WQ, Qin HD, Ruan HL, Shugart YY, Jia WH (2013) Quantitative association of tobacco smoking with the risk of nasopharyngeal carcinoma: a comprehensive meta-analysis of studies conducted between 1979 and 2011. Am J Epidemiol. doi: 10.1093/aje/kws479",
      "year": "2013"
    },
    {
      "author": "OA Kent",
      "journal-title": "Oncogene",
      "key": "9681_CR21",
      "unstructured": "Kent OA, Fox-Talbot K, Halushka MK (2012) RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets. Oncogene. doi: 10.1038/onc.2012.266",
      "year": "2012"
    },
    {
      "DOI": "10.1371/journal.pone.0054510",
      "author": "H Zhang",
      "doi-asserted-by": "crossref",
      "first-page": "e54510",
      "issue": "1",
      "journal-title": "PLoS ONE",
      "key": "9681_CR22",
      "unstructured": "Zhang H, Song J, Ren H, Xu Z, Wang X, Shan L, Fang J (2013) Detection of low-abundance KRAS mutations in colorectal cancer using microfluidic capillary electrophoresis-based restriction fragment length polymorphism method with optimized assay conditions. PLoS ONE 8(1):e54510. doi: 10.1371/journal.pone.0054510",
      "volume": "8",
      "year": "2013"
    },
    {
      "DOI": "10.1038/bjc.2013.109",
      "author": "NC Grieken van",
      "doi-asserted-by": "crossref",
      "first-page": "1495",
      "issue": "7",
      "journal-title": "Br J Cancer",
      "key": "9681_CR23",
      "unstructured": "van Grieken NC, Aoyma T, Chambers PA, Bottomley D, Ward LC, Inam I, Buffart TE, Das K, Lim T, Pang B, Zhang SL, Tan IB, Carvalho B, Heideman DA, Miyagi Y, Kameda Y, Arai T, Meijer GA, Tsuburaya A, Tan P, Yoshikawa T, Grabsch HI (2013) KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: results from a large international multicentre study. Br J Cancer 108(7):1495–1501. doi: 10.1038/bjc.2013.109",
      "volume": "108",
      "year": "2013"
    },
    {
      "DOI": "10.1007/BF02888197",
      "author": "L Liu",
      "doi-asserted-by": "crossref",
      "first-page": "336",
      "issue": "4",
      "journal-title": "J Tongji Med Univ",
      "key": "9681_CR24",
      "unstructured": "Liu L, Xiao C, Tao Y (2000) Detection and its implication of heat stress protein 27 and P21 in nasopharyngeal carcinoma. J Tongji Med Univ 20(4):336–337 (342)",
      "volume": "20",
      "year": "2000"
    },
    {
      "DOI": "10.1097/FPC.0b013e32835d9b0b",
      "author": "A Sebio",
      "doi-asserted-by": "crossref",
      "first-page": "142",
      "issue": "3",
      "journal-title": "Pharmacogenet Genomics",
      "key": "9681_CR25",
      "unstructured": "Sebio A, Pare L, Paez D, Salazar J, Gonzalez A, Sala N, del Rio E, Martin-Richard M, Tobena M, Barnadas A, Baiget M (2013) The LCS6 polymorphism in the binding site of let-7 microRNA to the KRAS 3′-untranslated region: its role in the efficacy of anti-EGFR-based therapy in metastatic colorectal cancer patients. Pharmacogenet Genomics 23(3):142–147. doi: 10.1097/FPC.0b013e32835d9b0b",
      "volume": "23",
      "year": "2013"
    },
    {
      "DOI": "10.1186/1471-2407-12-105",
      "author": "JZ Cerne",
      "doi-asserted-by": "crossref",
      "first-page": "105",
      "journal-title": "BMC Cancer",
      "key": "9681_CR26",
      "unstructured": "Cerne JZ, Stegel V, Gersak K, Novakovic S (2012) KRAS rs61764370 is associated with HER2-overexpressed and poorly-differentiated breast cancer in hormone replacement therapy users: a case control study. BMC Cancer 12:105. doi: 10.1186/1471-2407-12-105",
      "volume": "12",
      "year": "2012"
    },
    {
      "DOI": "10.1038/onc.2011.539",
      "author": "ES Ratner",
      "doi-asserted-by": "crossref",
      "first-page": "4559",
      "issue": "42",
      "journal-title": "Oncogene",
      "key": "9681_CR27",
      "unstructured": "Ratner ES, Keane FK, Lindner R, Tassi RA, Paranjape T, Glasgow M, Nallur S, Deng Y, Lu L, Steele L, Sand S, Muller RU, Bignotti E, Bellone S, Boeke M, Yao X, Pecorelli S, Ravaggi A, Katsaros D, Zelterman D, Cristea MC, Yu H, Rutherford TJ, Weitzel JN, Neuhausen SL, Schwartz PE, Slack FJ, Santin AD, Weidhaas JB (2012) A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer. Oncogene 31(42):4559–4566. doi: 10.1038/onc.2011.539",
      "volume": "31",
      "year": "2012"
    },
    {
      "author": "M Hoa",
      "first-page": "7154",
      "issue": "24",
      "journal-title": "Cancer Res",
      "key": "9681_CR28",
      "unstructured": "Hoa M, Davis SL, Ames SJ, Spanjaard RA (2002) Amplification of wild-type K-ras promotes growth of head and neck squamous cell carcinoma. Cancer Res 62(24):7154–7156",
      "volume": "62",
      "year": "2002"
    },
    {
      "DOI": "10.1016/S1470-2045(11)70044-4",
      "author": "T Paranjape",
      "doi-asserted-by": "crossref",
      "first-page": "377",
      "issue": "4",
      "journal-title": "Lancet Oncol",
      "key": "9681_CR29",
      "unstructured": "Paranjape T, Heneghan H, Lindner R, Keane FK, Hoffman A, Hollestelle A, Dorairaj J, Geyda K, Pelletier C, Nallur S, Martens JW, Hooning MJ, Kerin M, Zelterman D, Zhu Y, Tuck D, Harris L, Miller N, Slack F, Weidhaas J (2011) A 3′-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis. Lancet Oncol 12(4):377–386. doi: 10.1016/S1470-2045(11)70044-4",
      "volume": "12",
      "year": "2011"
    },
    {
      "DOI": "10.1038/tpj.2010.9",
      "author": "F Graziano",
      "doi-asserted-by": "crossref",
      "first-page": "458",
      "issue": "5",
      "journal-title": "Pharmacogenomics J",
      "key": "9681_CR30",
      "unstructured": "Graziano F, Canestrari E, Loupakis F, Ruzzo A, Galluccio N, Santini D, Rocchi M, Vincenzi B, Salvatore L, Cremolini C, Spoto C, Catalano V, D’Emidio S, Giordani P, Tonini G, Falcone A, Magnani M (2010) Genetic modulation of the Let-7 microRNA binding to KRAS 3′-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan. Pharmacogenomics J 10(5):458–464. doi: 10.1038/tpj.2010.9",
      "volume": "10",
      "year": "2010"
    }
  ],
  "reference-count": 30,
  "references-count": 30,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-013-9681-4"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Lack of association between let-7 binding site polymorphism rs712 and risk of nasopharyngeal carcinoma"
  ],
  "type": "journal-article",
  "volume": "13"
}